Zacks Investment Research Downgrades Koninklijke Philips (PHG) to Sell
Koninklijke Philips (NYSE:PHG) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Monday.
According to Zacks, “Philips is negatively impacted by higher restructuring and acquisition-related costs. The company is expected to hurt from slowing growth in the maturing personal care and domestic appliances market. Moreover, escalating trade war between the United States and China doesn’t bode well for the company, as it will raise prices to pass on the effect on consumers. This might hurt customer base expansion going forward. Moreover, the company is also under scrutiny from the FDA concerning a defibrillators dispute, which is expected to hurt EBITDA. However, Philips’ expanding portfolio is driving share price momentum, which has outperformed the industry on a year-to-date basis. The company continues to benefit from growing Diagnosis & Treatment business on the back of partnerships, expanding geographical coverage and innovative solutions.”
Other equities research analysts have also issued research reports about the company. BNP Paribas raised Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Monday, September 17th. Sanford C. Bernstein began coverage on Koninklijke Philips in a research note on Thursday, September 13th. They issued an “outperform” rating for the company. ValuEngine lowered Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Saturday, June 2nd. Finally, Exane BNP Paribas raised Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday, September 18th. One analyst has rated the stock with a sell rating, one has issued a hold rating and seven have given a buy rating to the stock. Koninklijke Philips currently has an average rating of “Buy” and an average price target of $48.00.
Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings results on Monday, July 23rd. The technology company reported $0.24 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by ($0.15). Koninklijke Philips had a return on equity of 7.81% and a net margin of 7.30%. The firm had revenue of $4.29 billion for the quarter, compared to the consensus estimate of $4.35 billion. During the same period last year, the firm earned $0.27 EPS. The company’s revenue for the quarter was down .1% on a year-over-year basis. equities research analysts anticipate that Koninklijke Philips will post 1.85 earnings per share for the current fiscal year.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Flagship Harbor Advisors LLC bought a new stake in shares of Koninklijke Philips in the 2nd quarter valued at about $110,000. Shufro Rose & Co. LLC bought a new stake in shares of Koninklijke Philips in the 2nd quarter valued at about $202,000. Park National Corp OH purchased a new position in Koninklijke Philips during the 2nd quarter valued at about $206,000. HRT Financial LLC purchased a new position in Koninklijke Philips during the 2nd quarter valued at about $206,000. Finally, Parsec Financial Management Inc. purchased a new position in Koninklijke Philips during the 2nd quarter valued at about $207,000. 4.86% of the stock is owned by institutional investors.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company worldwide. The company offers mother and child care, and oral healthcare products; male grooming and beauty products; kitchen appliance, coffee, air, garment care, and floor care products; and sleep, respiratory care, and respiratory drug delivery products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.